Analytical Data
-
基因名
ABT1
- Application
-
别名
ABT1; ABT1_HUMAN; Activator of basal transcription 1; Basal transcriptional activator 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9ULW3
-
表达区间
1-272aa
-
氨基酸序列
MEAEESEKAA TEQEPLEGTE QTLDAEEEQE ESEEAACGSK KRVVPGIVYL GHIPPRFRPL HVRNLLSAYG EVGRVFFQAE DRFVRRKKKA AAAAGGKKRS YTKDYTEGWV EFRDKRIAKR VAASLHNTPM GARRRSPFRY DLWNLKYLHR FTWSHLSEHL AFERQVRRQR LRAEVAQAKR ETDFYLQSVE RGQRFLAADG DPARPDGSWT FAQRPTEQEL RARKAARPGG RERARLATAQ DKARSNKGLL ARIFGAPPPS ESMEGPSLVR DS
-
分子量
31.0 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ABT1 recombinant protein has garnered significant attention in the field of molecular biology and biochemistry due to its potential therapeutic applications and importance in understanding cellular processes. Identified as a key player in various signaling pathways, ABT1 is involved in regulating cell growth and apoptosis, making it a target of interest for cancer research. The ability to produce recombinant proteins like ABT1 facilitates detailed biochemical studies and allows researchers to dissect its function and interactions within cellular systems. Furthermore, understanding the structure-function relationship of ABT1 through recombinant technology could lead to the development of novel therapeutic strategies. As researchers continue to explore its role in disease mechanisms, particularly in cancer and other proliferation-related disorders, the study of ABT1 recombinant protein holds promise for advancing personalized medicine and targeted therapies. The ongoing exploration into its mechanism of action, coupled with innovative protein engineering approaches, underscores the importance of ABT1 in both basic research and potential clinical applications.
